Apomorphine hydrochloride: Clinical Trials

3 trials of Apomorphine hydrochloride, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2
Phase 21Completed 1

Follow Apomorphine hydrochloride: new trials by email Literature Review of Apomorphine hydrochloride trials Research Report on Apomorphine hydrochloride

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
APL-130277, subcutaneous apomorphine - Motor OFF Episodes Associated With Parkinson's Disease
Phase 3CompletedSumitomo Pharma America, Inc.1132018-12-192022-12-16
Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease
Apomorphine hydrochloride, Placebo - Parkinson's Disease
Phase 3CompletedBritannia Pharmaceuticals Ltd.1072014-03-032019-07-08
Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy
apomorphine hydrochloride - Parkinson's Disease
Phase 2CompletedKyowa Kirin Co., Ltd.162007-11-012020-08-28

Conditions studied

Parkinson Disease (3)

Sponsors

Britannia Pharmaceuticals Ltd. (1)  ·  Kyowa Kirin Co., Ltd. (1)  ·  Sumitomo Pharma America, Inc. (1)

Countries

Austria (2)  ·  France (2)  ·  Germany (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Denmark (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)

Top investigators

Regina Katzenschlager, Doz. Dr. (1)

Results publications

PMID 30055903, PMID 33486139

NIH funding

2016 (1)